21
Participants
Start Date
May 31, 2007
Primary Completion Date
July 31, 2010
Study Completion Date
October 31, 2012
Tarceva and Rapamycin
Tarceva will be administered once a day for 28 days without interruption. THen Rapamycin will be administered, orally twice daily, in combination with the Tarceva for the remainder of the study.
Children's Research Institute, Washington D.C.
Collaborators (1)
Children's National Research Institute
OTHER
Roger Packer
OTHER